Folliculin: A Regulator of Transcription Through AMPK and MTOR Signaling Pathways

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2021 May 13

PMID 33981707

Citations 28

Authors

Josue M J Ramirez Reyes

Rafael Cuesta

Arnim Pause

Affiliations

Soon will be listed here.

Abstract

is a tumor suppressor gene responsible for the inherited Birt-Hogg-Dubé (BHD) syndrome, which affects kidneys, skin and lungs. FLCN is a highly conserved protein that forms a complex with folliculin interacting proteins 1 and 2 (FNIP1/2). Although its sequence does not show homology to known functional domains, structural studies have determined a role of FLCN as a GTPase activating protein (GAP) for small GTPases such as Rag GTPases. FLCN GAP activity on the Rags is required for the recruitment of mTORC1 and the transcriptional factors TFEB and TFE3 on the lysosome, where mTORC1 phosphorylates and inactivates these factors. TFEB/TFE3 are master regulators of lysosomal biogenesis and function, and autophagy. By this mechanism, FLCN/FNIP complex participates in the control of metabolic processes. AMPK, a key regulator of catabolism, interacts with FLCN/FNIP complex. FLCN loss results in constitutive activation of AMPK, which suggests an additional mechanism by which FLCN/FNIP may control metabolism. AMPK regulates the expression and activity of the transcriptional cofactors PGC1α/β, implicated in the control of mitochondrial biogenesis and oxidative metabolism. In this review, we summarize our current knowledge of the interplay between mTORC1, FLCN/FNIP, and AMPK and their implications in the control of cellular homeostasis through the transcriptional activity of TFEB/TFE3 and PGC1α/β. Other pathways and cellular processes regulated by FLCN will be briefly discussed.

Citing Articles

STING-induced noncanonical autophagy regulates endolysosomal homeostasis.

Huang T, Sun C, Du F, Chen Z Proc Natl Acad Sci U S A. 2025; 122(8):e2415422122.

PMID: 39982740 PMC: 11874320. DOI: 10.1073/pnas.2415422122.

Variants in Parathyroid Carcinoma and Atypical Parathyroid Tumors.

Burke C, Bellizzi J, Costa-Guda J, Arnold A J Endocr Soc. 2025; 9(2):bvaf009.

PMID: 39885950 PMC: 11781200. DOI: 10.1210/jendso/bvaf009.

Genome-wide association analysis of composite sleep health scores in 413,904 individuals.

Goodman M, Faquih T, Paz V, Nagarajan P, Lane J, Spitzer B Commun Biol. 2025; 8(1):115.

PMID: 39856408 PMC: 11760956. DOI: 10.1038/s42003-025-07514-0.

YTHDF3-mediated FLCN/cPLA2 axis improves cardiac fibrosis via suppressing lysosomal function.

Zhang Y, Diao H, Leng M, Wu Y, Huang B, Li X Acta Pharmacol Sin. 2025; .

PMID: 39806064 DOI: 10.1038/s41401-024-01425-2.

Plasmodium berghei liver stage parasites exploit host GABARAP proteins for TFEB activation.

Schmuckli-Maurer J, Bindschedler A, Wacker R, Wurgler O, Rehmann R, Lehmberg T Commun Biol. 2024; 7(1):1554.

PMID: 39572689 PMC: 11582615. DOI: 10.1038/s42003-024-07242-x.

References

Baba M, Endoh M, Ma W, Toyama H, Hirayama A, Nishikawa K . Folliculin Regulates Osteoclastogenesis Through Metabolic Regulation. J Bone Miner Res. 2018; 33(10):1785-1798. PMC: 6220829. DOI: 10.1002/jbmr.3477. View

Hasumi H, Baba M, Hong S, Hasumi Y, Huang Y, Yao M . Identification and characterization of a novel folliculin-interacting protein FNIP2. Gene. 2008; 415(1-2):60-7. PMC: 2727720. DOI: 10.1016/j.gene.2008.02.022. View

Hasumi Y, Baba M, Hasumi H, Huang Y, Lang M, Reindorf R . Folliculin (Flcn) inactivation leads to murine cardiac hypertrophy through mTORC1 deregulation. Hum Mol Genet. 2014; 23(21):5706-19. PMC: 4189904. DOI: 10.1093/hmg/ddu286. View

Hong S, Oh H, Valera V, Baba M, Schmidt L, Linehan W . Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization. PLoS One. 2011; 5(12):e15793. PMC: 3012117. DOI: 10.1371/journal.pone.0015793. View

Zhou Q, Gu Y, Lang H, Wang X, Chen K, Gong X . Dihydromyricetin prevents obesity-induced slow-twitch-fiber reduction partially via FLCN/FNIP1/AMPK pathway. Biochim Biophys Acta Mol Basis Dis. 2017; 1863(6):1282-1291. DOI: 10.1016/j.bbadis.2017.03.019. View

Rosenwald I, Sonenberg N, SCHMIDT E . Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E. Mol Cell Biol. 1993; 13(12):7358-63. PMC: 364806. DOI: 10.1128/mcb.13.12.7358-7363.1993. View

Woodford M, Dunn D, Blanden A, Capriotti D, Loiselle D, Prodromou C . The FNIP co-chaperones decelerate the Hsp90 chaperone cycle and enhance drug binding. Nat Commun. 2016; 7:12037. PMC: 4931344. DOI: 10.1038/ncomms12037. View

Faubert B, Boily G, Izreig S, Griss T, Samborska B, Dong Z . AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo. Cell Metab. 2013; 17(1):113-24. PMC: 3545102. DOI: 10.1016/j.cmet.2012.12.001. View

Ma X, Liu H, Murphy J, Foyil S, Godar R, Abuirqeba H . Regulation of the transcription factor EB-PGC1α axis by beclin-1 controls mitochondrial quality and cardiomyocyte death under stress. Mol Cell Biol. 2015; 35(6):956-76. PMC: 4333088. DOI: 10.1128/MCB.01091-14. View

10.

Dodding M . Folliculin - A tumor suppressor at the intersection of metabolic signaling and membrane traffic. Small GTPases. 2016; 8(2):100-105. PMC: 5464117. DOI: 10.1080/21541248.2016.1204808. View

11.

Lin J, Handschin C, Spiegelman B . Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab. 2005; 1(6):361-70. DOI: 10.1016/j.cmet.2005.05.004. View

12.

Goncharova E, Goncharov D, James M, Atochina-Vasserman E, Stepanova V, Hong S . Folliculin controls lung alveolar enlargement and epithelial cell survival through E-cadherin, LKB1, and AMPK. Cell Rep. 2014; 7(2):412-423. PMC: 4034569. DOI: 10.1016/j.celrep.2014.03.025. View

13.

Mathieu J, Detraux D, Kuppers D, Wang Y, Cavanaugh C, Sidhu S . Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency. Nat Commun. 2019; 10(1):632. PMC: 6367455. DOI: 10.1038/s41467-018-08020-0. View

14.

Baba M, Hong S, Sharma N, Warren M, Nickerson M, Iwamatsu A . Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling. Proc Natl Acad Sci U S A. 2006; 103(42):15552-7. PMC: 1592464. DOI: 10.1073/pnas.0603781103. View

15.

Laviolette L, Mermoud J, Calvo I, Olson N, Boukhali M, Steinlein O . Negative regulation of EGFR signalling by the human folliculin tumour suppressor protein. Nat Commun. 2017; 8:15866. PMC: 5493755. DOI: 10.1038/ncomms15866. View

16.

Bar-Peled L, Chantranupong L, Cherniack A, Chen W, Ottina K, Grabiner B . A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1. Science. 2013; 340(6136):1100-6. PMC: 3728654. DOI: 10.1126/science.1232044. View

17.

Paquette M, El-Houjeiri L, Zirden L, Puustinen P, Blanchette P, Jeong H . AMPK-dependent phosphorylation is required for transcriptional activation of TFEB and TFE3. Autophagy. 2021; 17(12):3957-3975. PMC: 8726606. DOI: 10.1080/15548627.2021.1898748. View

18.

Erlich A, Brownlee D, Beyfuss K, Hood D . Exercise induces TFEB expression and activity in skeletal muscle in a PGC-1α-dependent manner. Am J Physiol Cell Physiol. 2017; 314(1):C62-C72. PMC: 5866381. DOI: 10.1152/ajpcell.00162.2017. View

19.

Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H . Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 2002; 3(6):889-901. DOI: 10.1016/s1534-5807(02)00369-6. View

20.

Evans T, Zhang X, Jeong S, He A, Song E, Bhattacharya S . TFEB drives PGC-1α expression in adipocytes to protect against diet-induced metabolic dysfunction. Sci Signal. 2019; 12(606). PMC: 6882500. DOI: 10.1126/scisignal.aau2281. View